Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies.
<h4>Aims</h4>HaemoglobinA1c (HbA1c) is recommended for diabetes diagnosis but fasting plasma glucose (FPG) has been useful for identifying patients with glucokinase (GCK) mutations which cause lifelong persistent fasting hyperglycaemia. We aimed to derive age-related HbA1c reference rang...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0065326&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850224569073270784 |
|---|---|
| author | Anna M Steele Kirsty J Wensley Sian Ellard Rinki Murphy Maggie Shepherd Kevin Colclough Andrew T Hattersley Beverley M Shields |
| author_facet | Anna M Steele Kirsty J Wensley Sian Ellard Rinki Murphy Maggie Shepherd Kevin Colclough Andrew T Hattersley Beverley M Shields |
| author_sort | Anna M Steele |
| collection | DOAJ |
| description | <h4>Aims</h4>HaemoglobinA1c (HbA1c) is recommended for diabetes diagnosis but fasting plasma glucose (FPG) has been useful for identifying patients with glucokinase (GCK) mutations which cause lifelong persistent fasting hyperglycaemia. We aimed to derive age-related HbA1c reference ranges for these patients to determine how well HbA1c can discriminate patients with a GCK mutation from unaffected family members and young-onset type 1 (T1D) and type 2 diabetes (T2D) and to investigate the proportion of GCK mutation carriers diagnosed with diabetes using HbA1c and/or FPG diagnostic criteria.<h4>Methods</h4>Individuals with inactivating GCK mutations (n = 129), familial controls (n = 100), T1D (n = 278) and T2D (n = 319) aged ≥18years were recruited. Receiver Operating Characteristic (ROC) analysis determined effectiveness of HbA1c and FPG to discriminate between groups.<h4>Results</h4>HbA1c reference ranges in subjects with GCK mutations were: 38-56 mmol/mol (5.6-7.3%) if aged ≤40years; 41-60 mmol/mol (5.9-7.6%) if >40years. All patients (123/123) with a GCK mutation were above the lower limit of the HbA1c age-appropriate reference ranges. 69% (31/99) of controls were below these lower limits. HbA1c was also effective in discriminating those with a GCK mutation from those with T1D/T2D. Using the upper limit of the age-appropriate reference ranges to discriminate those with a mutation from those with T1D/T2D correctly identified 97% of subjects with a mutation. The majority (438/597 (73%)) with other types of young-onset diabetes had an HbA1c above the upper limit of the age-appropriate GCK reference range. HbA1c ≥48 mmol/mol classified more people with GCK mutations as having diabetes than FPG ≥7 mmol/l (68% vs. 48%, p = 0.0009).<h4>Conclusions</h4>Current HbA1c diagnostic criteria increase diabetes diagnosis in patients with a GCK mutation. We have derived age-related HbA1c reference ranges that can be used for discriminating hyperglycaemia likely to be caused by a GCK mutation and aid identification of probands and family members for genetic testing. |
| format | Article |
| id | doaj-art-df92ecf3aeb543689f6b75eaa90a8068 |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-df92ecf3aeb543689f6b75eaa90a80682025-08-20T02:05:35ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0186e6532610.1371/journal.pone.0065326Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies.Anna M SteeleKirsty J WensleySian EllardRinki MurphyMaggie ShepherdKevin ColcloughAndrew T HattersleyBeverley M Shields<h4>Aims</h4>HaemoglobinA1c (HbA1c) is recommended for diabetes diagnosis but fasting plasma glucose (FPG) has been useful for identifying patients with glucokinase (GCK) mutations which cause lifelong persistent fasting hyperglycaemia. We aimed to derive age-related HbA1c reference ranges for these patients to determine how well HbA1c can discriminate patients with a GCK mutation from unaffected family members and young-onset type 1 (T1D) and type 2 diabetes (T2D) and to investigate the proportion of GCK mutation carriers diagnosed with diabetes using HbA1c and/or FPG diagnostic criteria.<h4>Methods</h4>Individuals with inactivating GCK mutations (n = 129), familial controls (n = 100), T1D (n = 278) and T2D (n = 319) aged ≥18years were recruited. Receiver Operating Characteristic (ROC) analysis determined effectiveness of HbA1c and FPG to discriminate between groups.<h4>Results</h4>HbA1c reference ranges in subjects with GCK mutations were: 38-56 mmol/mol (5.6-7.3%) if aged ≤40years; 41-60 mmol/mol (5.9-7.6%) if >40years. All patients (123/123) with a GCK mutation were above the lower limit of the HbA1c age-appropriate reference ranges. 69% (31/99) of controls were below these lower limits. HbA1c was also effective in discriminating those with a GCK mutation from those with T1D/T2D. Using the upper limit of the age-appropriate reference ranges to discriminate those with a mutation from those with T1D/T2D correctly identified 97% of subjects with a mutation. The majority (438/597 (73%)) with other types of young-onset diabetes had an HbA1c above the upper limit of the age-appropriate GCK reference range. HbA1c ≥48 mmol/mol classified more people with GCK mutations as having diabetes than FPG ≥7 mmol/l (68% vs. 48%, p = 0.0009).<h4>Conclusions</h4>Current HbA1c diagnostic criteria increase diabetes diagnosis in patients with a GCK mutation. We have derived age-related HbA1c reference ranges that can be used for discriminating hyperglycaemia likely to be caused by a GCK mutation and aid identification of probands and family members for genetic testing.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0065326&type=printable |
| spellingShingle | Anna M Steele Kirsty J Wensley Sian Ellard Rinki Murphy Maggie Shepherd Kevin Colclough Andrew T Hattersley Beverley M Shields Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies. PLoS ONE |
| title | Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies. |
| title_full | Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies. |
| title_fullStr | Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies. |
| title_full_unstemmed | Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies. |
| title_short | Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies. |
| title_sort | use of hba1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation observational case control studies |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0065326&type=printable |
| work_keys_str_mv | AT annamsteele useofhba1cintheidentificationofpatientswithhyperglycaemiacausedbyaglucokinasemutationobservationalcasecontrolstudies AT kirstyjwensley useofhba1cintheidentificationofpatientswithhyperglycaemiacausedbyaglucokinasemutationobservationalcasecontrolstudies AT sianellard useofhba1cintheidentificationofpatientswithhyperglycaemiacausedbyaglucokinasemutationobservationalcasecontrolstudies AT rinkimurphy useofhba1cintheidentificationofpatientswithhyperglycaemiacausedbyaglucokinasemutationobservationalcasecontrolstudies AT maggieshepherd useofhba1cintheidentificationofpatientswithhyperglycaemiacausedbyaglucokinasemutationobservationalcasecontrolstudies AT kevincolclough useofhba1cintheidentificationofpatientswithhyperglycaemiacausedbyaglucokinasemutationobservationalcasecontrolstudies AT andrewthattersley useofhba1cintheidentificationofpatientswithhyperglycaemiacausedbyaglucokinasemutationobservationalcasecontrolstudies AT beverleymshields useofhba1cintheidentificationofpatientswithhyperglycaemiacausedbyaglucokinasemutationobservationalcasecontrolstudies |